Skip to main
ATR

Aptargroup (ATR) Stock Forecast & Price Target

Aptargroup (ATR) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

AptarGroup has demonstrated strong performance with its AMS Solutions segment, achieving approximately 10% compound annual growth rate (CAGR) and contributing about 5% to the overall revenue forecast for FY24. The company’s Injectables business is also experiencing significant growth, reflecting a 9% CAGR due to increasing demand for biologics and GLP-1s, which is expected to drive further margin expansion. With the Pharma segment accounting for more than two-thirds of AptarGroup's profits, the continued advancements in both AMS Solutions and Injectables present a solid foundation for the company's financial outlook.

Bears say

AptarGroup faces significant risks that could hinder its financial performance, particularly its transition to a majority Pharma focus, which may take longer than anticipated, thereby limiting growth potential and margin expansion. The company’s global operations expose it to various currency and country risks, compounded by the potential impact of economic cycles on industry demand. Additionally, challenges such as regulatory inspections, trade tensions, and the inability to protect intellectual property may further undermine its competitive advantages and revenue stability.

Aptargroup (ATR) has been analyzed by 4 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aptargroup and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aptargroup (ATR) Forecast

Analysts have given Aptargroup (ATR) a Buy based on their latest research and market trends.

According to 4 analysts, Aptargroup (ATR) has a Buy consensus rating as of Dec 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $167.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $167.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aptargroup (ATR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.